Patents by Inventor Julie Carette

Julie Carette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
    Patent number: 7737251
    Abstract: This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular, this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastrointestinal functions, from any segment of the gastrointestinal tract, from the oesophagus to the anus.
    Type: Grant
    Filed: December 23, 2005
    Date of Patent: June 15, 2010
    Assignee: ConjuChem Biotechnologies Inc.
    Inventors: Dominique P. Bridon, Nissab Boudjellab, Roger Leger, Martin Robitaille, Karen Thibaudeau, Julie Carette
  • LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS
    Publication number: 20090312259
    Abstract: This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular, this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastrointestinal functions, from any segment of the gastrointestinal tract, from the oesophagus to the anus.
    Type: Application
    Filed: July 19, 2009
    Publication date: December 17, 2009
    Inventors: Dominique P. Bridon, Nissab Boudjellab, Roger Leger, Martin Robitaille, Karen Thibaudeau, Julie Carette
  • LONG LASTING NATRIURETIC PEPTIDE DERIVATIVES
    Publication number: 20090275506
    Abstract: This invention relates to long lasting natriuretic peptide (NP) derivatives. The NP derivative has a NP peptide and a reactive entity coupled to the NP peptide. The reactive entity is able to covalently bond with a functionality on a blood component. In particular, this invention relates to NP derivatives having an extended in vivo half-life, and method for the treatment of cardiovascular diseases and disorders such as acute decompensated congestive heart failure (CHF) and chronic CHF.
    Type: Application
    Filed: October 17, 2008
    Publication date: November 5, 2009
    Applicant: Conjuchem Biotechnologies, Inc.
    Inventors: Peter BAKIS, Dominique P. Bridon, Julie Carette, France LeClaire, Roger Leger, Martin Robitaille
  • Long Lasting Natriuretic Peptide Derivatives
    Publication number: 20080199532
    Abstract: This invention relates to long lasting natriuretic peptide (NP) derivatives. The NP derivative has a NP peptide and a reactive entity coupled to the NP peptide. The reactive entity is able to covalently bond with a functionality on a blood component. In particular, this invention relates to NP derivatives having an extended in vivo half-life, and method for the treatment of cardio-vascular diseases and disorders such as acute decompensated congestive heart failure (CHF) and chronic CHF.
    Type: Application
    Filed: October 29, 2007
    Publication date: August 21, 2008
    Inventors: Peter Bakis, Dominique P. Bridon, Julie Carette, France Leclaire, Roger Leger, Martin Robitaille
  • Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
    Publication number: 20060217304
    Abstract: This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular, this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastrointestinal functions, from any segment of the gastrointestinal tract, from the oesophagus to the anus.
    Type: Application
    Filed: December 23, 2005
    Publication date: September 28, 2006
    Inventors: Dominique Bridon, Nissab Boudjellab, Roger Leger, Martin Robitaille, Karen Thibaudeau, Julie Carette
  • Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
    Patent number: 7112567
    Abstract: This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastrointestinal functions, from any segment of the gastrointestinal tract, from the oesophagus to the anus.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: September 26, 2006
    Assignee: ConjuChem Inc.
    Inventors: Dominique P. Bridon, Nissab Boudjellab, Roger Léger, Martin Robitaille, Karen Thibaudeau, Julie Carette
  • Long lasting natriuretic peptide derivatives
    Publication number: 20050176641
    Abstract: This invention relates to long lasting natriuretic peptide (NP) derivatives. The NP derivative has a NP peptide and a reactive entity coupled to the NP peptide. The reactive entity is able to covalently bond with a functionality on a blood component. In particular, this invention relates to NP derivatives having an extended in vivo half-life, and method for the treatment of cardiovascular diseases and disorders such as acute decompensated congestive heart failure (CHF) and chronic CHF.
    Type: Application
    Filed: January 21, 2005
    Publication date: August 11, 2005
    Applicant: CONJUCHEM, INC.
    Inventors: Peter Bakis, Dominique Bridon, Julie Carette, France Leclaire, Roger Leger, Martin Robitaille
  • Long lasting natriuretic peptide derivatives
    Publication number: 20040266673
    Abstract: This invention relates to long lasting natriuretic peptide (NP) derivatives. The NP derivative has a NP peptide and a reactive entity coupled to the NP peptide. The reactive entity is able to covalently bond with a functionality on a blood component. In particular, this invention relates to NP derivatives having an extended in vivo half-life, and method for the treatment of cardio-vascular diseases and disorders such as acute decompensated congestive heart failure (CHF) and chronic CHF.
    Type: Application
    Filed: September 8, 2003
    Publication date: December 30, 2004
    Inventors: Peter Bakis, Dominique P. Bridon, Julie Carette, France Leclaire, Roger Leger, Martin Robitaille
  • Long lasting glucagon-like peptide2(glp-2)for the treatment of gastrointestinal diseases and disorders
    Publication number: 20040248782
    Abstract: This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular, this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastrointestinal functions, from any segment of the gastrointestinal tract, from the oesophagus to the anus.
    Type: Application
    Filed: August 12, 2002
    Publication date: December 9, 2004
    Inventors: Dominique P. Bridon, Nissab Boudjellab, Roger Leger, Martin Robitaille, Karen Thibaudeau, Julie Carette